Peter Vu

Also affiliated with University of California San Diego

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “540 Impact of elexacaftor-tezacaftor-ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function, and fat malabsorption: Report of PROMISE PEDS GI”.

540 Impact of elexacaftor-tezacaftor-ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function, and fat malabsorption: Report of PROMISE PEDS GI

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01463-7

N/A

0DataRank · unranked

0 citations

Peter Vu, S. Schwarzenberg, Ben Freedman, M R Narkewicz, J. Pittman +4 more

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007927

N/A

0DataRank · unranked

33 citations

Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia +13 more

Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedside

Therapeutic Advances in Neurological Disorders(2024)10.1177/17562864241252718

N/A

0DataRank · unranked

7 citations

Daniel Briggi, Peter Vu, Jianguo Cheng, Lin Feng, Jijun Xu +1 more